About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Drug Used for Heart Failure Inhibits Herpes Virus Infection

by Julia Samuel on March 15, 2016 at 4:46 PM
Font : A-A+

Drug Used for Heart Failure Inhibits Herpes Virus Infection

Antiviral medicines against herpes viruses are limited and if the virus become resistant to these frontline treatments, there are no alternative drugs to serve as backup.

Herpes virus is a family of viruses that cause mononucleosis, herpes, and shingles, among other illnesses.

Advertisement


In search for new drugs to treat viral infections, scientists from the University of Utah School of Medicine found that a medicine routinely used to treat heart failure, spironolactone, has an unexpected ability to block infection by Epstein Barr virus (EBV), a herpes virus that causes mono and is associated with several human cancers.

They find that the drug's antiviral properties stem from its ability to block a key step in viral infection that is common to all herpes viruses. Spironolactone's target is distinct from that of existing drugs, revealing that it could be developed into a new class of anti-herpesvirus drug.
Advertisement

"It's remarkable that a drug we have used safely in the clinic for over 50 years is also an effective EBV inhibitor," says senior author Sankar Swaminathan, chief of infections disease at University of Utah Health Care and professor of internal medicine. "It goes to show how basic research can reveal things we would never have found otherwise."

Swaminathan's team uncovered spironolactone's antiviral properties in a screen to identify drugs that work through a mechanism that is different from that of existing anti-herpes virus drugs.

Currently available drugs block a middle step of the viral infection cycle by inhibiting virus' ability to replicate DNA. They found that like these drugs, spironolactone can block EBV replication in cells, but it does so by targeting the so-called SM protein, required for a late step in the infection cycle.

Importantly, spironolactone's ability to block viral infection appears to be independent from its ability to treat heart failure. Previous studies showed that the drug treats heart failure through a different, metabolic mechanism. This study demonstrates that a drug similar to spironolactone shares its ability to treat heart failure but not its antiviral properties. Together the results suggest the two mechanisms are separable.

"We think there is great potential to modify this molecule so that it can work as an antiviral without having undesired side effects," explains Swaminathan. Spironolactone could be developed as a new medicine against EBV, a common and dangerous infection among transplant and other immunocompromised patients.

But because all herpes viruses depend on SM-like proteins to spread infection, the work also has broader implications. Spironolactone could be a template for a new class of drug directed against all herpes viruses.

"We have found a new therapeutic target for herpes viruses," says Swaminathan. "We think it can be developed it into a new class of antiviral drugs to help overcome the problem of drug resistant infections."



Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Baldness can be Cured and Prevented: let us see How!
Drinking Beer or Wine Every Day Could Cause Age-related Diseases
Low-Calorie Diet for Diabetes
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Drug Toxicity Cold Sores Shingles Shigellosis Congenital Heart Disease Signature Drug Toxicity Heart Healthy Heart Flu 

Most Popular on Medindia

Drug Interaction Checker Blood - Sugar Chart Pregnancy Confirmation Calculator Daily Calorie Requirements Find a Doctor Loram (2 mg) (Lorazepam) Hearing Loss Calculator Drug Side Effects Calculator Calculate Ideal Weight for Infants Indian Medical Journals
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use